Skip to main content
All lobbying filings

Tiber Creek Group

Tiber Creek Group filed a Q3 report for Astrazeneca on October 19, 2025, reporting $90,000 in lobbying income.

Lobbying for Astrazeneca

As filed: TIBER CREEK GROUP for ASTRAZENECA.

All filings by Tiber Creek Group · Everything Astrazeneca has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 19, 2025
Income
$90,000
What the client paid this registrant for the period.

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Drug Rebate Program (MDRP); Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.

Health Issues

Issues related to the 340B Program - Public Health Service Act (P.L. 78-410).

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem